Testosterone Therapy Frequently Prescribed Without Recommended Diagnostic Workup
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Read MorePosted by CLP Edit Staff | Jun 15, 2026 | Clinical Chemistry, Diabetes & Metabolic Diseases, Immunoassay |
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Read MorePosted by CLP Edit Staff | May 27, 2026 | Cardiovascular, Company News, Diabetes & Metabolic Diseases |
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Lab Management |
A study of over 84,000 patient records by Vivica and ACCU Reference Medical Lab found that more than 80% of at-risk patients missed recommended follow-up lab tests, highlighting gaps in care identified through laboratory data.
Read MorePosted by CLP Edit Staff | May 18, 2026 | Diabetes & Metabolic Diseases |
As diabetes testing evolves, labs are seeing growing interest in earlier screening, additional biomarkers, and tools that can support more preventive care.
Read MorePosted by CLP Edit Staff | Apr 29, 2026 | Cancer, Company News, Molecular Diagnostics |
ClearNote Health will present data at DDW 2026 showing its Avantect Pancreatic Cancer Test achieved 82.6% sensitivity and 97.5% specificity in patients at elevated risk.
Read More